Journals / Retina-Vitreus / 2011 / Cilt: 19 - Sayı: 1

Clinical course and prognosis in branch retinal vein occlusion

Retina ven dal tıkanıklarında klinik seyir ve prognoz

Pages
46–49
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

There is an affirmative effect of the argon laser photocaoagulation and intravitreal drug injection to the prognosis in selected cases.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Purpose: To investigate etiology, age, gender, follow-up time, accompanying eye examination findings, and outcomes of treatments in cases with branch retinal vein occlusion.
📊
Key Findings & Data:Material and Methods: Eighty four eyes of 78 patients with branch retinal vein occlusion that were followed-up in Turkish Ministry of Health Ankara Ulucanlar Eye Education and Research Hospital Retina Clinic between 2008 and 2010 were retrospectively evaluated in this study.
💡
Conclusion & Impact:There is an affirmative effect of the argon laser photocaoagulation and intravitreal drug injection to the prognosis in selected cases.
🔬Design:Research Article
📍Scope:2008 Verileri
⚙️Variables:Domain Parameters

Abstract

Purpose: To investigate etiology, age, gender, follow-up time, accompanying eye examination findings, and outcomes of treatments in cases with branch retinal vein occlusion. Material and Methods: Eighty four eyes of 78 patients with branch retinal vein occlusion that were followed-up in Turkish Ministry of Health Ankara Ulucanlar Eye Education and Research Hospital Retina Clinic between 2008 and 2010 were retrospectively evaluated in this study. A complete ophthalmological examination including visual acuity, intraocular pressure with applanation tonometry, biomicroscobic examination findings, dilated pupil examination of the posterior segment, optic coherence tomography, and fluorescein angiography were evaluated at baseline and during follow-up period. Results: There were 40 male (51.2%) and 38 female (48.8%). The average age of patients was 61.1 years (35-83 years). Mean follow up period was 7.9 months (6-24 months). Eighty four eyes of 78 patients were involved. Nine patients (11.6%) had bilateral involvement. Hypertension in 47 eyes (55.9%), diabetes mellitus in 15 eyes (17.9%), cardiovascular disease in 4 eyes (4.7%), hematologic problems in 3 eyes (3.6 %), and vasculitis in 1 eye (1.2%) were detected as etiologic causes. No causes were found in 14 eyes (16.7%). Argon laser photocoagulation alone in 27 eyes (32.1%), intravitreal triamcinolone injection with argon laser photocoagulation in 15 eyes (17.9%), intravitreal triamcinolone injection alone in 8 eyes (9.5%), intravitreal bevacizumab injection with argon laser photocoagulation in 7 eyes (8.3%), intravitreal bevacizumab injection alone in 3 eyes (3.6%), intravitreal bevacizumab and intravitreal triamcinolone injection with argon laser photocoagulation in 2 eyes (2.4%) were used. Twenty two eyes (26.2%) followed without treatment. Conclusion: Based on the results that were obtained in this series, hypertension was the most common cause in cases with branch retinal vein occlusion. Unilateral involvement was seen in these cases in general. There is an affirmative effect of the argon laser photocaoagulation and intravitreal drug injection to the prognosis in selected cases.

Özet

Amaç: Retina ven dal tıkanıklığı tanısı ile takip edilen olguların etiyoloji, yaş, cinsiyet, takip süresi, eşlik eden muayene bulguları ve uygulanan tedavinin sonuçlarını incelemek. Gereç ve Yöntem: 2008-2010 yılları arasında Ulucanlar Göz Eğitim ve Araştırma Hastanesi Retina bölümünde retina ven dal tıkanıklığı tanısı ile takip edilen 78 hastanın 84 gözü geriye dönük olarak incelendi. Olguların başlangıç ve takip muayenelerinde görme değerleri, göz içi basıncı değerleri, biyomikroskopi bulguları ve göz dibi muayenesi, optik koherens tomografi ve floresein anjiyografiyi içeren muayene bulguları değerlendirildi. Sonuçlar: Olguların 40’ı erkek (%51.2), 38’si kadın (%48.8) idi. Olguların ortalama yaşı 61.1 yıldı (35-83 yıl). Takip süreleri ortalama 7.9 ay (6-24 ay) idi. Toplam 78 olgunun 84 gözü tutulmuştu. Dokuz olguda (%11.6) iki taraflı göz tutulumu mevcuttu. Etiyolojik neden olarak, 47 gözde (%55.9) hipertansiyon, 15 gözde (%17.9) diyabet, 4 gözde (%4.7) kardiyovasküler hastalık, 3 gözde (%3.6) kanama ve pıhtılaşma bozukluğu, 1 gözde (%1.2) vaskulit tespit edilirken, 14 olguda (%16.7) ise sebep bulunamadı. Tedavi olarak 27 göze (%32.1) argon lazer fotokoagülasyonu tedavisi, 15 göze (%17.9) argon lazer fotokoagülasyonu ile birlikte intravitreal triamsinolon enjeksiyonu, 8 göze (%9.5) intravitreal triamsinolon enjeksiyonu, 7 göze (%8.3) argon lazer fotokoagülasyonu ile birlikte intravitreal bevacizumab enjeksiyonu, 3 göze (%3.6) intravitreal bevacizumab enjeksiyonu, 2 göze (%2.4) intravitreal triamsinolon ile birlikte intravitreal bevacizumab enjeksiyonu ve argon lazer fotokoagülasyonu uygulandı. Yirmi iki göz (%26.2) ise tedavisiz takip edildi. Tartışma: Bu serideki sonuçlara göre, retina ven tıkanıklarında en sık neden hipertansiyondur. Genellikle bu olgularda tek taraflı tutuluma rastlanmaktadır. Seçilmiş gözlerde uygulanan argon lazer fotokoagülasyonu ve intravitreal ilaç enjeksiyonunun prognoza olumlu etkisi mevcuttur.

🔖

Cite This Article

ÇITIRIK, M., TAŞDEMİR, S., BEYAZYILDIZ, E., ÖZKAN, S. S. (2011). Clinical course and prognosis in branch retinal vein occlusion. Retina-Vitreus, Cilt: 19 - Sayı: 1, 46–49. https://ajindex.com/articles/307713

References (17)

  1. Branch Vein Occlusion Study Group. Argon laser photocoagulation for macular edema in branch vein occlusion. Am J Ophtalmol. 1984;98:271-282
  2. David R, Zangwill L, Badarna M, et al.: Epidemiology of retinal vein occlusion and its association with glaucoma and increase intraocular pressure. Ophthalmologica.1988;97:69-74
  3. Morley MG, Heier JS.: Venous obstructive disease of the retina. In Ophthalmology. Yanoff M, Duker JS, eds. Mosby: St. Louis, MO. 2004:864-871
  4. Zhao J, Sastry SM, Sperduto RD, et al.: Arteriovenous crossing patterns in branch retinal vein occlusion. The Eye Disease Case-Control Study Group. Ophthalmology.1993;100:423-428
  5. Joffe L, Goldberg RE, Magargal LE, et al.: Macular branch vein occlusion. Ophthalmology 1980:87;91-98
  6. Sperduto RD, Hiller R, Chew E, et al.: Risk factors for hemiretinal vein occlusion: comparison with risk factors for central and branch retinal vein occlusion: the eye disease case-control study. Ophthalmology. 1998;105:765-771
  7. Hayreh SS.: Central retinal vein occlusion. Ophthalmology Clinics of North America. 1998;11:559-590
  8. Frangieh GT, Green WR, Barraquer-Sommers E, et al.: Histopathologic study of nine branch retinal vein occlusions. Arch Ophthalmol. 1982;100:1132-1140
  9. Appiah AP, Trempe CL.: Risk factors associated with branch vs. central retinal vein occlusion. Ann. Ophthalmol. 1989;21:153-155
  10. The eye Disease Case-Control Study Group: Risk factors of branch retinal vein occlusion. Am J Ophthalmol. 1993;116:286-296
  11. Frucht J, Shapiro A, Merin S.: Intraocular pressure in retinal vein occlusion. Br J Ophthalmol. 1984;68:26-28
  12. Luntz MH, Schenker HI.: Retinal vascular accidents in glaucoma and ocular hypertension. Surv Ophthalmol. 1980;25:163-167
  13. Fonk ACO, Schatz H.: Central retinal vein occlusion in young adults. Surv Ophthalmol. 1993;37:393-417
  14. Rath EZ, Frank RN, Shin DH, et al.: Risk factors for retinal vein occlusion. A case-control study. Ophthalmology. 1992;99:509-514
  15. Gürelik G, Özdek Ş, Aydın B ve ark.: Retinal ven dal tıkanıklığı tedavisinde arteriyovenöz kılıf dekompresyonu. Ret-Vit. 2003;11: 47-53
  16. Cheng KC, Wu WC, Chen KJ.: Intravitreal triamcinolone acetonide vs bevacizumab for treatment of macular oedema secondary to branch retinal vein occlusion. Eye. 2009;23:2023-2033
  17. Karaçorlu SA, Karaçorlu M, Özdemir H.: Retina ven dal tıkanıklığında intravitreal triamsinolon asetonid tedavisi sonrası maküladaki değişikliklerin incelenmesi. Ret-Vit. 2005;1